Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VIROPHARMA INC Analyst Recommendations

  • Analyst Consensus: VPHM

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.182 Buy 11
    30 Days Ago 2.417 Buy 12
    60 Days Ago 2.417 Buy 12
    90 Days Ago 2.455 Buy 11
    120 Days Ago 2.500 Hold 12
  • Analyst Ratings: VPHM

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    ThinkEquity Source of Funds Buy 10/29/2009
    Oppenheimer Perform Outperform 09/28/2009 13.00
    ThinkEquity Buy Accumulate 06/05/2009
    ThinkEquity Buy 04/28/2009 7.00
    Deutsche Securities Hold 02/10/2009 8.00
    Maxim Group Buy 02/10/2009 8.50
    Stanford Research Buy 02/10/2009 10.00
    JMP Securities Mkt Outperform 02/09/2009 10.00
    Lazard Capital Buy 02/09/2009 11.00
    Rodman & Renshaw Mkt Outperform 02/09/2009 10.00
    Credit Suisse Outperform Neutral 02/09/2009 6.00
    Deutsche Securities Hold 01/19/2009 12.00
    Oppenheimer Perform 11/20/2008
    Credit Suisse Outperform 11/11/2008 15.00
    Janney Mntgmy Scott Buy 11/06/2008
    Stanford Research Hold Buy 10/13/2008 13.00
    Rodman & Renshaw Mkt Perform Mkt Outperform 10/13/2008 18.00
    JMP Securities Mkt Outperform 07/31/2008 18.00
    Stanford Research Buy Hold 07/18/2008 11.00
    Stanford Research Buy 06/03/2008 13.00
    JMP Securities Mkt Outperform 03/14/2008
    Janney Mntgmy Scott Neutral Buy 03/12/2008
    Lazard Capital Buy 08/10/2007 18.00
    Cowen & Co Neutral 08/08/2007
    Maxim Group Buy 06/28/2007 18.00
    JMP Securities Mkt Outperform 05/03/2007 21.00
    Rodman & Renshaw Mkt Perform 05/03/2007
    Lazard Capital Buy 04/16/2007 24.00
    Susquehanna Financial Positive Neutral 04/02/2007
    JMP Securities Mkt Outperform 02/28/2007 18.00